In a groundbreaking achievement, prime editing technology successfully corrected a genetic mutation in hematopoietic stem cells, reversing the effects of CGD—a debilitating condition that compromises the immune system. This innovative approach offers new hope for patients facing severe infections and inflammatory diseases due to this mutation. Developed by a U.S.-based company, this advancement showcases the potential of genetic editing in treating rare illnesses, highlighting the power of precision medicine in addressing complex genetic disorders.
Read more from sciencex.com
